Morning Breakouts

Latest KFF Health News Stories

‘Real Danger’: Low-Income Nations Fall Into ‘Have-Not’ Vaccine Status

Morning Briefing

Only one African nation has begun to vaccinate and others might not have vaccines until 2023. Public health experts say vaccine inequality will prolong the epidemic and possibly allow variants to emerge.

Vaccine Fight Heats Up In Europe As UK Passes Grim Covid Milestone

Morning Briefing

The number of covid victims in the United Kingdom has eclipsed the number of civilians killed in World War II. Meanwhile, solidarity between the U.K. and E.U. is fraying, several nations have passed new mask rules, Holocaust survivors are receiving their first doses of the vaccine and more.

FDA Issues Alert About Mexico’s Hand Sanitizers

Morning Briefing

The agency said sanitizers, if laced with methanol, can be toxic when absorbed or not effective. News reports look at a cat with covid in Arkansas, the safest masks, and falling birth rates in the U.S.

HCA Healthcare Says It Will Share Patient Data With Covid Researchers

Morning Briefing

Dr. Jonathan Perlin, chief medical officer of the Nashville, Tenn.-based health system, said sharing information will “accelerate what is known about covid and its treatment, and by doing so, save lives.” Names will be removed, HCA says.

‘We’re Letting Science Speak Again’: Health Experts Renew Covid Briefings

Morning Briefing

Starting today, federal health officials and scientists will take the lead on briefing Americans three times a week about the state of the pandemic. News outlets report on other aspects of the Biden administration’s covid and health care plans, as well.

Good News On Monoclonal Antibodies Keeps Rolling In From Clinical Trials

Morning Briefing

Regeneron said Tuesday that its antibody cocktail of casirivimab and imdevimab can prevent covid. And Eli Lilly, fresh off similar news last week, said Tuesday that a cocktail of bamlanivimab and etesevimab significantly reduces hospitalizations and deaths.

CDC Finds In-Person School With Safety Precautions Fuels Few Outbreaks

Morning Briefing

Researchers with the Centers for Disease Control and Prevention looked at data from the fall semester and found it to be “reassuring” about the dangers of covid transmission in schools when masks and distancing are employed.

Johnson & Johnson: 100 Million Doses Of Vaccine By June For US

Morning Briefing

The company expects results of its phase 3 trial by next week, and once its vaccine is approved, it would be the third vaccine in the U.S. Sanofi, while awaiting development of its vaccine, says it can help manufacture Pfizer’s beginning this summer.

Biden Aims To Boost Vaccine Supply With 200M More Doses

Morning Briefing

The Biden administration wants to purchase enough additional covid vaccine from Moderna and Pfizer to inoculate all American adults by the end of summer. He also announced plans to try to smooth immediate distributions efforts to the states.